http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2542155-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0e40d8e7082c36e138bed3476aaca4b3
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4184
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H30-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4015
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0491
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-675
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4015
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4184
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-055
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-24
filingDate 2011-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_10b38173a96d2b69efe5e1022b9d31fa
publicationDate 2013-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-2542155-A2
titleOfInvention Cancer diagnosis and imaging
abstract The present invention provides a method for imaging a disease or condition in a mammal which includes the steps of; administering a therapeutically effective amount of a cell cycle inhibitor to effectively stop proliferation of eukaryotic cells at a cell cycle checkpoint between the G1 and S phase, stopping administration of the cell cycle inhibitor for a period of time, administering a marker to the mammal and imaging the mammal.
priorityDate 2010-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008018642-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02092127-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0015845-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006003020-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226433345
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226424915
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4122
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66659296
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11764616
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226675362
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID119171
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226675363
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400382
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53635755
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60663
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226433344
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127386781

Total number of triples: 40.